April 23, 2018 / 12:34 PM / a month ago

BRIEF-Ultragenyx Announces Filing And FDA Clearance Of An Investigational New Drug Application For DTX401

April 23 (Reuters) - Ultragenyx Pharmaceutical Inc:

* ULTRAGENYX ANNOUNCES FILING AND FDA CLEARANCE OF AN INVESTIGATIONAL NEW DRUG APPLICATION FOR DTX401, A GENE THERAPY FOR THE TREATMENT OF GLYCOGEN STORAGE DISEASE TYPE IA

* ULTRAGENYX PHARMACEUTICAL INC - ENROLLMENT IN PHASE 1/2 STUDY OF DTX401 TO BEGIN IN H1 2018, WITH DATA FROM FIRST COHORT EXPECTED IN H2 OF 2018 Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below